Pfizer fight with Starboard heats up, hedge fund alleges executive pressure
The corporate clash between Pfizer and Starboard Value heated up on Thursday when the activist investment firm pressed the U.S. drugmaker to investigate actions by its board, after two former executives backed out of its campaign against the company.
Starboard Value alleged that Pfizer officials threatened legal action against two former top executives who had been working ...
Former Pfizer Inc. executives Ian Read and Frank D’Amelio have decided “not to be involved” in Starboard Value’s activist ...
Pfizer CEO Albert Bourla reportedly is planning to meet with Starboard Value after the activist investor took a $1 billion ...
Pfizer’s situation with activist investor Starboard Value is already getting messy. | After initially supporting a meeting ...
Former Pfizer CEO Ian Read and ex-CFO Frank D'Amelio said they will not be involved with activist investor Starboard Value, ...
Some misleading narratives about Bourla’s leadership that have been put forward have been distinctly unfair,' write Jeff ...
With one headline, Pfizer had gone from being a well-known hunter — spending heavily to buy rivals — to the hunted.
Key Takeaways Pfizer shares have gained ground since a report over the weekend said that activist investor Starboard Value ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback